HER2/neu as target in gastric adenocarcinoma
Künye
Cetin, B., & Ozet, A. (2016). HER2/neu as target in gastric adenocarcinoma. Translational gastroenterology and hepatology, 1, 59. https://doi.org/10.21037/tgh.2016.06.08Özet
Gastric adenocarcinoma (GAC), a heterogeneous disease characterized by epidemiologic and histopathologic differences across countries, is a leading cause of cancer-related death.